These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23704674)

  • 1. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.
    TODAY Study Group
    Diabetes Care; 2013 Jun; 36(6):1749-57. PubMed ID: 23704674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on: TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013;36:1749-1757.
    Baldi JC; Manning PJ; Hofman PL; Walker RJ
    Diabetes Care; 2013 Dec; 36(12):e223. PubMed ID: 24265392
    [No Abstract]   [Full Text] [Related]  

  • 3. Adiponectin, Insulin Sensitivity, β-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY.
    Arslanian S; El Ghormli L; Bacha F; Caprio S; Goland R; Haymond MW; Levitsky L; Nadeau KJ; White NH; Willi SM;
    Diabetes Care; 2017 Jan; 40(1):85-93. PubMed ID: 27803118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial.
    TODAY Study Group
    Diabetes Care; 2021 Jan; 44(1):75-80. PubMed ID: 33290248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure.
    Arslanian S; El Ghormli L; Haymond MH; Chan CL; Chernausek SD; Gandica RG; Gubitosi-Klug R; Levitsky LL; Siska M; Willi SM;
    Pediatr Diabetes; 2020 Jun; 21(4):575-585. PubMed ID: 32064729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.
    Kahn SE; Lachin JM; Zinman B; Haffner SM; Aftring RP; Paul G; Kravitz BG; Herman WH; Viberti G; Holman RR;
    Diabetes; 2011 May; 60(5):1552-60. PubMed ID: 21415383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study.
    Narasimhan S; Weinstock RS
    Mayo Clin Proc; 2014 Jun; 89(6):806-16. PubMed ID: 24702733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.
    Marcus MD; Wilfley DE; El Ghormli L; Zeitler P; Linder B; Hirst K; Ievers-Landis CE; van Buren DJ; Walders-Abramson N;
    Pediatr Obes; 2017 Aug; 12(4):337-345. PubMed ID: 27161901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
    Retnakaran R; Qi Y; Harris SB; Hanley AJ; Zinman B
    Diabetes Care; 2011 Jul; 34(7):1601-4. PubMed ID: 21709296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth Hormone Mediators and Glycemic Control in Youths With Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
    Lu C; Wolfs D; El Ghormli L; Levitsky LL; Levitt Katz LE; Laffel LM; Patti ME; Isganaitis E
    JAMA Netw Open; 2024 Feb; 7(2):e240447. PubMed ID: 38421647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.
    ; Zeitler P; Epstein L; Grey M; Hirst K; Kaufman F; Tamborlane W; Wilfley D
    Pediatr Diabetes; 2007 Apr; 8(2):74-87. PubMed ID: 17448130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.
    RISE Consortium
    Diabetes Care; 2018 Aug; 41(8):1717-1725. PubMed ID: 29941500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in β-Cell Function in TODAY.
    Arslanian S; El Ghormli L; Young Kim J; Bacha F; Chan C; Ismail HM; Levitt Katz LE; Levitsky L; Tryggestad JB; White NH;
    Diabetes Care; 2019 Jan; 42(1):164-172. PubMed ID: 30455329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study.
    Bacha F; Pyle L; Nadeau K; Cuttler L; Goland R; Haymond M; Levitsky L; Lynch J; Weinstock RS; White NH; Caprio S; Arslanian S;
    Pediatr Diabetes; 2012 Aug; 13(5):376-83. PubMed ID: 22332798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
    Kelsey MM; Braffett BH; Geffner ME; Levitsky LL; Caprio S; McKay SV; Shah R; Sprague JE; Arslanian SA;
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2309-2318. PubMed ID: 29697830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of glycemia with insulin sensitivity and β-cell function in adults with early type 2 diabetes on metformin alone.
    Utzschneider KM; Younes N; Rasouli N; Barzilay J; Banerji MA; Cohen RM; Gonzalez EV; Mather KJ; Ismail-Beigi F; Raskin P; Wexler DJ; Lachin JM; Kahn SE;
    J Diabetes Complications; 2021 May; 35(5):107912. PubMed ID: 33752962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.